Emily M. Leproust, Chief Executive Officer at Twist Bioscience, sold TWST on Aug 10, 2026
Data as of Oct 16
▼ SELL$14.2M113,318 shares at $125.16Emily M. Leproust Chief Executive OfficerTWST Twist Bioscience Corp
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TWST since disclosure
+6.0%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Aug 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.